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Abstract
Background: Among patients suffering from coronary heart disease (CHD) and comorbid depression, women
experience a higher burden compared to men. Little is known on the characteristics that differentiate men and women
with both diseases and whether these factors mediate gender effects on depression. This study assessed whether
women are more likely to suffer from depression and which characteristics mediate gender effects on depression
among a cardiac population in Palestine, specifically addressing the role of post-traumatic stress disorder (PTSD).
Methods: Using a cross-sectional design, patients consecutively admitted with a CHD to one of the four main hospitals
in Nablus, Palestine, were interviewed using a structured questionnaire with validated instruments. Data was also
obtained from hospital medical records. Patients were assessed for depression using the Cardiac Depression Scale (CDS).
Bivariate analysis was conducted to compare characteristics of women and men with and without depressive symptoms.
Mediators (direct and indirect effects) of the association between gender and depression were evaluated using a
structural equation model (SEM).
Results: Women were more likely to suffer from severe depression than men (28.7% vs. 18.8%). Female gender was
positively associated with higher PTSD symptoms, comorbidities, somatic symptoms and income, and with lower
resilience, self-esteem, quality of life, education, prevalence of smoking and physical activity. Structural equation
modeling revealed negative indirect effects of gender on depression (CDS score) through resilience, self-esteem and
physical activity, whereas positive indirect effects of gender on depression were observed through PTSD, comorbidities,
somatic symptoms and smoking. There was no direct effect of gender on depression.
Conclusion: This study found a higher prevalence of severe depression in female patients with cardiac disease
compared to male cardiac patients. Our findings provide novel information on mediating factors of the association
between gender and depression among cardiac patients, in particular PTSD. The results emphasize the need for further
research on potential mediating factors that could account for gender differences in depression and the need to provide
support programs for female patients with comorbid CHD and depression to improve their psycho-social well-being.
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Introduction
Depression is an increasingly recognized risk factor for
cardiovascular disease (CVD), particularly coronary heart
disease (CHD) [1, 2]. The prevalence of depression
among cardiac patients ranges from 15 to 30%, which is
considerably higher than in the general population [3].
Depression in cardiac patients is associated with poor
outcomes [4], long-term prognosis [5], overall quality of
life [6], mortality [1], and a dose-response relationship
has been reported between depressive symptom level
and subsequent mortality [7].
Depression is up to two times higher in women than in
men [8, 9]. Many factors could explain these differences
including biological, genetic, psychological and social dif-
ferences between women and men [10]. Gender and sex
are often used interchangeably suggesting biological and
psychosocial attributes vary with one another [11]. While
sex denotes genetic and biological characteristics, gender
refers to the array of socially constructed roles and rela-
tionships, personality traits, attitudes, behaviors and values
that society ascribes to the sexes on a differential basis
[12]. However, the use of the term sex as a ‘stand-alone in-
dicator of biology’ is rejected as gendered experiences
materialize in the body and measures of sex can include
effects of gender [13]. In the case of depression and in the
presence of sex differences, biology alone cannot provide
an accurate explanation. Higher depression rates are
found in women than men due to stressors related to so-
cial roles whereas lower rates of depression are found
among men because male-attributed symptoms of depres-
sion such as anger, aggression, irritation, and abusive be-
havior are commonly not recognized as depressive
symptoms [14]. Evidence suggests that women underpriv-
ileged in different aspects of life suffer from greater
stressors and poorer health than men, including mental
disorders and chronic diseases [15]. Women also report
poorer health than men due to lack of access to healthcare
and due to the stressors caused by their gender and
marital roles [16, 17].
The role of gender for CHD has been addressed exten-
sively in literature since the 1980’s [6, 18]. Studies have
reported that being female is associated with higher
mortality and morbidity after cardiac events compared
to being male [19, 20] and that women are likely to de-
velop more depressive symptoms associated with CHD
than men [21]. A meta-analysis found an overall preva-
lence of comorbid major depression of 18.7% in women
compared to 12.0% in men. In particular, women are
more vulnerable after coronary artery bypass graft
(CABG) compared to men, suffer from more comorbid
illness [22], are more likely to experience anxiety and
more likely to be socially isolated [23]. Among myocar-
dial infarction (MI) patients, women report less social
support and more role disruption during recovery [24]
and are two times more prone to depression post-MI
than men [25]. Therefore, female cardiac patients have a
higher risk of suffering from adverse effects of depres-
sion on the prognosis of their disease [1, 9, 26]. In
addition, women have greater symptom frequency, ex-
perience greater risk of re-infarction, have lower survival
rates after CABG and higher rates of subsequent heart
failure (HF) compared to men [27–29]. In several stud-
ies, the worse cardiac outcomes in women persist after
adjustment for age, medical history, clinical severity,
hospital treatment, and cardiac procedures [28, 30–32].
Despite the burden observed in women due to comorbid
CHD and depression, they continue to be understudied
in research and data are often not presented by gender.
The high burden of CVD and the rise of depression rates
among women in the general population as well as in
CHD populations call for assessment of the gender gap
in depression. There is scarce literature on characteris-
tics that distinguish men and women with comorbid
CHD and depression. Furthermore, whether these fac-
tors mediate gender effects on depression in cardiac pa-
tients remains unclear. This ultimately makes it difficult
to identify women at higher risk of adverse outcomes as-
sociated with both CHD and depression. In this paper,
the terms sex and gender as well as women and men are
used: ‘gender’ as an overarching notion; ‘sex’ when refer-
ring to associations reported in the literature for being
female and male respectively; and the terms ‘women’
and ‘men’ to denote population subgroups.
Post-traumatic stress disorder (PTSD) is also a com-
mon co-morbid condition in cardiac patients [33] and
rates are higher among female cardiac patients. PTSD
has been associated with recurrent MI, hospitalizations
and mortality [34, 35]. Similarly, PTSD exhibits gender-
specific patterns and is known to be comorbid with de-
pression [36].
Previous literature has focused on gender differ-
ences in depression among heart disease patients
mainly in high income countries [18, 27]. In Middle
Eastern countries, CVD accounts for 34% of all deaths
and PTSD is high among individuals living in regions
of conflict [37]. The Occupied Palestinian Territories
(oPt) in particular, report high rates of depression in
response to the stressful living conditions. The differ-
ent societal roles of women and the evidence based
CVD-gender differences call for more research into
the understanding of gender-related factors with re-
gard to depression and mediating factors among car-
diac patients. In this study, we sought to assess
whether Palestinian women are more likely to suffer
from depression than Palestinian men among a sam-
ple of 1022 consecutively admitted cardiac patients at
one of the four major hospitals in the West Bank city
of Nablus, Palestine, and to investigate whether socio-
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demographic, clinical, psychosocial and lifestyle char-
acteristics mediate gender effects on depression, espe-
cially addressing the role of PTSD.
Methods
Study design and population
This cross-sectional hospital-based study was conducted
on consecutive patients aged 30–80 years admitted to
the cardiology and cardiac surgery departments at one
of the four main hospitals in Nablus, Palestine, during
their stay in the hospital (1–7 days) between March 2017
and November 2017. They were included in the study if
they were diagnosed with CHD, ST elevation or non-ST
elevation MI, angina, HF, cardiac arrhythmia, valve dis-
ease or any other cardiac disease. Patients with a normal
cardiac catheterization (CATH), an acute or past stroke,
end-stage kidney disease (including dialysis patients),
peripheral vascular disease, psychological disorders, cog-
nitive deficit, neurological disorders (dementia, Alzhei-
mer’s disease, epilepsy, Parkinson’s disease), use of
antidepressant or any other condition affecting the qual-
ity of their responses were excluded from the study. A
total of 1092 patients were approached and met initial
eligibility requirements, and 1053 agreed to participate
in the study. The analytic sample included 1022 subjects.
The study was approved by the Ethics Committee of
Nordwest-und Zentral Schweiz (EKNZ) in Basel,
Switzerland, and by the Institutional Review Board (IRB)
committee at An-Najah National University in Nablus,
Palestine.
Data collection
Eligible patients were approached for private in-person
interviews using hospital registries and written informed
consent was obtained from those who agreed to partici-
pate. Prior to completion of the interview, socio-demo-
graphic and clinical characteristics including: age,
gender, marital status, residence, education level, occu-
pation, income; current diagnosis, previous cardiac diag-
noses, years with cardiac disease, cardiac treatment (at
admission), co-morbidities, medications and family his-
tory of CVD were retrieved from patients’ medical re-
cords and were ascertained via patient interview. In-
person interviews consisted of a sequence of validated
instruments assessing physical and psychosocial factors
and questions assessing lifestyle factors.
Study measurements
Depressive symptoms were assessed by the Cardiac De-
pression Scale (CDS), a disease-specific, 26-item ques-
tionnaire used to accurately measure depression in
patients with CVD. The CDS is scored based on a Likert
scale ranging from strongly disagree (1) to strongly agree
(7). Total scores are calculated as the sum of the scores
of each item and range from 26 to 182 [38]. The CDS
can be used as a continuous measure, where higher
scores indicate more severe depressive symptoms, or as
an ordinal indicator of possible depression using previ-
ously established cut-off points which include: < 90 for
no depression; 90–100 for mild to moderate depression;
and >100 for severe depression. These cut offs were used
in the current study to categorize depressive symptoms.
The CDS has a sensitivity of 88% and a specificity of
84% for severe depression when a cutoff of > 100 is used,
and 84% sensitivity and 78% specificity for cutoff scores
of 90–100 [39]. Further instruments used include the
Post-Traumatic Stress Disorder Checklist (PTSD-PCL-S)
[40]; Enhancing Recovery in Coronary Heart Social Sup-
port Instrument (ESSI) [41, 42]; Resilience Scale-14 (RS-
14) [43]; Single-Item Self-Esteem Scale (SISE) [44];
Short-form 12 Health Survey (SF-12-PCS; SF-12-MCS)
[45] and the Patient Health Questionnaire-15 (PHQ-15)
[46]. The instruments have been described in detail else-
where [47].
Statistical analyses
Depressive symptoms were examined both as a continu-
ous variable (CDS score) and as a dichotomous variable
(presence of moderate-severe depressive symptoms
using the standard cutoff of CDS ≥90). Characteristics of
women and men with and without depressive symptoms
were compared using Chi-squared or Fisher exact tests
for categorical variables, and independent t-tests for
continuous variables, as appropriate.
A structural equation model (SEM) was built to assess
direct and indirect (i.e. mediated) effects of gender on de-
pression. Mediators are variables which transfer part of
the effect of an independent variable (IV) on a dependent
variable (DV). In our analysis, the IV was gender (used as
a binary variable, with “being female” coded as 1), the DV
was depression (CDS score, used as a continuous variable),
and the potential mediator variables were socio-
demographic, clinical, psychosocial and lifestyle factors
[48]. First, mediator groups (i.e. socio-demographic, clin-
ical, psychosocial and lifestyle factors) were assessed in
separate models. In a second step, the final model was
built (reference model, N = 1022), including education, in-
come, comorbidities, somatic symptoms, quality of life,
PTSD, resilience, self-esteem, smoking, physical activity.
These potential mediators were chosen based on 1) their
statistical significance in the preceding analyses, using a
cut-off level of p < 0.10 2) the magnitude of their associ-
ation 3) whether the associations were significant between
gender and the potential mediator, as well as between the
potential mediator and depression (CDS score). The SEM
was estimated using the maximum likelihood method and
included continuous, binary and ordinal variables which
were all treated as continuous. Inclusion of a larger
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number of potential mediators reduces bias in estimating
the true direct effect of gender on depression (CDS score).
Potential confounding factors assessed were age, marital
status, occupation, social support, and lifestyle factors (i.e.
BMI, alcohol consumption). A further SEM-analysis was
then conducted stratifying by age, running separate
models for two age groups (those aged below and above
the median age of 59 years; see Additional file 1: Figure
S1a and b). Moderation by age was assessed by testing the
differences between corresponding age-specific effects
using Chi-squared tests. In further analyses, two additional
SEM’s were computed to assess whether resilience and
smoking could be potential mediators and/or moderators
of the effect of PTSD on depression, adding the respective
factor as mediator between PTSD and depression and
testing its interaction with PTSD to assess potential mod-
eration. This additional analysis was based on general
conceptualization and literature on psychological comor-
bidity of PTSD and depression [36, 49]. Analysis was con-
ducted using the STATA Statistical Software Release 15
(StataCorp., College Station, U.S.A.).
Results
This sample consisted of 750 (73.4%) men and 272
(26.6%) women. Among the cardiac patients with de-
pressive symptoms, 231 (28.7%) were women. In con-
trast, among patients without depressive symptoms, 41
(18.8%) were women. Socio-demographic, clinical, psy-
chosocial and lifestyle factors of depressed and non-de-
pressed men and women are presented in Table 1. In
terms of socio-demographic factors, among those with
depressive symptoms, women were on average older
than men, more likely to be unmarried (i.e. single,
widowed), less educated, unemployed and have no in-
come compared to men.
Differences among women and men with depressive
symptoms in terms of clinical factors were also found.
Women with depressive symptoms were more likely to
have a severe cardiac disease (i.e. heart failure, mitral or
aortic valve stenosis) compared to men with depressive
symptoms who had mostly CHD or a MI diagnosis,
more likely to report a previous cardiac diagnosis,
undergo a CATH/complex procedure (i.e. valve replace-
ment), have two or more comorbid conditions (i.e. dia-
betes, hypertension, the combination of both), take three
to four medications, have higher somatic symptoms and
to score lower on the SF-12-PCS for quality of life.
Bivariate comparisons of psychosocial factors between
depressed men and women revealed that depressed
women were more likely to have higher levels of PTSD
symptoms, lower social support, lower resilience, lower
self-esteem and a lower score on the SF-12-MCS for
quality of life than their male counterparts.
Regarding lifestyle factors, women with depressive
symptoms were less likely to be smokers and have a high
fat intake, while more likely to be physically inactive and
to be obese than men with depressive symptoms.
In the sample without depressive symptoms, the pat-
tern of gender differences was similar, but with the small
sample of women without depression (n = 41), significant
differences were observed less frequently.
The presence of depressive symptoms as defined by a
CDS score ≥ 90 among the total sample was 78.7%. The
proportion of severe depressive symptoms (CDS > 100)
was higher in women compared to men (61.4% versus
50.7%, P = 0.003), while the proportion of women without
depressive symptoms was 15.1% versus 23.6% for men
(Table 2). Comparison of depressive and PTSD symptoms
assessed as continuous variables (means of CDS and
PTSD scores) by gender revealed that women had signifi-
cantly higher CDS (104.6 ± 15.9; t = 4.1; P < 0.001) and
PTSD scores (29.4 ± 10.6; t = 4.4; P < 0.001) (Fig. 1).
Direct and indirect effects of gender on depression (CDS
score)
The pooled SEM of the direct effect of gender on de-
pression (CDS score) and the indirect effects when me-
diators were added was conducted for the overall
sample. Figure 2 illustrates the pathways between gender
and depression with the tested mediators. Parameters re-
ported in the figure include coefficients and confidence
intervals (CI). They demonstrate the associations of gen-
der with each potential mediating factor and between
each potential mediating factor and outcome variable,
after adjusting for the effect of gender. Results from the
SEM showed both positive and negative mediators,
where positive mediators mediating the gender differ-
ence on depression are associated both with being fe-
male and higher levels of depression. In the pooled SEM
of gender and depression, there was no direct effect of
gender on CDS score (coefficient: 0.0, 95% CI: − 2.2-2.2,
p = 1.0). There were significant direct effects of gender
on the mediators as shown in Fig. 2. On the one hand,
female gender was positively associated with higher
PTSD symptoms, comorbidities, somatic symptoms and
income. On the other hand, female gender was associ-
ated with lower resilience, self-esteem, quality of life,
education, less smoking and lower physical activity.
Negative indirect effects of gender on depression were
observed through resilience, self-esteem, quality of life,
(SF-12-PCS), education, income and physical activity,
whereas positive indirect effects of gender on depression
were observed through PTSD, comorbidities, somatic
symptoms, and smoking. Quality of life, education, and
income were not significant mediators for the indirect
effect of gender on depression. No evidence of moder-
ation was found for the direct effect of gender on CDS
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Table 1 Bivariate comparison of study characteristics in men and women with CVD, by presence and absence of depressive
symptoms, N = 1022
Variable Sample with depressive Symptoms (CDS ≥90)
(N = 804)
Sample without depressive symptoms (CDS < 90)
(N = 218)
Male
(N = 573) N (%)
Female
(N = 231) N (%)
P value Male
(N = 177) N (%)
Female
(N = 41) N (%)
P value
Socio-demographic factors
Age, mean (SD)a 57.9 ± 9.6 61.6 ± 10.5 < 0.001 57.8 ± 10.2 63.7 ± 10.7 0.001
Marital status < 0.001 < 0.001
Married 564 (98.4) 171 (74.0) 166 (93.8) 25 (60.7)
Not married 9 (1.6) 60 (26.0) 11 (6.2) 16 (39.0)
Residence 0.456 0.723
City 261 (45.5) 104 (45.0) 89 (50.3) 20 (48.8)
Village 270 (47.1) 104 (45.0) 79 (44.6) 20 (48.8)
Camp 42 (7.3) 23 (10.0) 9 (5.1) 1 (2.4)
Education degree < 0.001 0.004
No HS diploma 298 (52.0) 188 (81.4) 84 (47.4) 30 (73.2)
HS diploma 173 (30.2) 32 (13.8) 49 (27.7) 9 (21.9)
College degree 102 (17.8) 11 (4.8) 44 (24.9) 2 (4.9)
Occupation < 0.001 < 0.001
Professional 153 (26.7) 9 (3.9) 47 (26.6) 0 (0.0)
Non-professional 226 (39.4) 4 (1.7) 76 (42.9) 1 (2.4)
Unemployed 143 (25.0) 175 (75.8) 31 (17.5) 29 (70.8)
Retired 51 (8.9) 4 (1.7) 23 (13.0) 3 (7.3)
House wife 0 (0.0) 39 (16.9) 0 (0.0) 8 (19.5)
Income < 0.001 < 0.001
Yes 442 (77.1) 77 (33.3) 146 (82.5) 12 (29.3)
No 131 (22.9) 154 (66.7) 31 (17.5) 29 (70.7)
Clinical Factors
Cardiac diagnosis < 0.001 0.010
CHD 188 (32.8) 63 (27.3) 70 (39.6) 13 (31.7)
MI 242 (42.2) 76 (32.9) 73 (41.2) 15 (36.6)
Angina 96 (16.8) 38 (16.4) 24 (13.6) 4 (9.8)
Other 47 (8.2) 54 (23.4) 10 (5.6) 9 (21.9)
Previous cardiac diagnosis 0.036 0.898
Yes 386 (67.4) 173 (74.9) 106 (59.9) 25 (61.0)
No 187 (32.6) 58 (25.1) 71 (40.1) 16 (39.0)
Years with cardiac disease 0.356 0.800
≤1 year 347 (60.6) 130 (56.3) 124 (70.1) 27 (65.8)
2–9 years 148 (25.8) 61 (26.4) 37 (20.9) 9 (22.0)
≥ 10 years 78 (13.6) 40 (17.3) 16 (9.0) 5 (12.2)
Cardiac treatment (at admission) 0.005 0.872
CATH/stent 306 (53.4) 98 (42.4) 107 (60.5) 23 (56.0)
CATH/CABG 139 (24.3) 58 (25.1) 34 (19.2) 9 (22.0)
CATH/other & unknown 128 (22.3) 75 (32.5) 36 (20.3) 9 (22.0)
Co-morbidities < 0.001 0.021
None 182 (31.8) 32 (13.9) 73 (41.2) 12 (29.3)
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Table 1 Bivariate comparison of study characteristics in men and women with CVD, by presence and absence of depressive
symptoms, N = 1022 (Continued)
Variable Sample with depressive Symptoms (CDS ≥90)
(N = 804)
Sample without depressive symptoms (CDS < 90)
(N = 218)
Male
(N = 573) N (%)
Female
(N = 231) N (%)
P value Male
(N = 177) N (%)
Female
(N = 41) N (%)
P value
1 169 (29.5) 68 (29.4) 57 (32.2) 9 (22.0)
2+ 222 (38.7) 131 (56.7) 47 (26.6) 20 (48.7)
Medications 0.003 0.471
None 81 (14.1) 13 (5.6) 32 (18.1) 6 (14.6)
1–2 85 (14.9) 37 (16.0) 22 (12.4) 8 (19.5)
3–4 407 (71.0) 181 (78.4) 123 (69.5) 27 (65.8)
Somatic symptoms (PHQ-15) < 0.001 0.046
Minimal 48 (8.4) 6 (2.6) 35 (19.8) 2 (4.9)
Low 118 (20.6) 34 (14.7) 74 (41.8) 15 (36.6)
Medium 193 (33.7) 64 (27.7) 43 (24.3) 14 (34.1)
High 214 (37.3) 127 (55.0) 25 (14.1) 10 (24.4)
Family history 0.356 0.033
Yes 236 (41.2) 87 (37.7) 63 (35.6) 22 (53.7)
No 337 (58.8) 144 (62.3) 114 (64.4) 19 (46.3)
QoL, (SF-12-PCS score), mean (SD)a 38.2 ± 12.1 31.4 ± 10.1 < 0.001 44.6 ± 12.1 34.4 ± 1.9 < 0.001
Psychosocial factors
PTSD (PTSD-PCL-S) < 0.001 0.282
Minimal 329 (57.4) 105 (45.4) 147 (83.1) 30 (73.2)
Some 66 (11.5) 15 (6.5) 11 (6.2) 3 (7.3)
Moderate 141 (24.6) 85 (36.8) 19 (10.7) 8 (19.5)
High 37 (6.5) 26 (11.3) 0 (0.0) 0 (0.0)
Social support (ESSI) < 0.001 0.293
Low 186 (32.5) 108 (46.7) 54 (30.5) 16 (39.0)
High 387 (67.5) 123 (53.3) 123 (69.5) 25 (61.0)
Resilience (RS-14) < 0.001 0.002
Very low 45 (7.9) 38 (16.4) 3 (1.7) 6 (14.6)
Low 55 (9.6) 38 (16.4) 8 (4.5) 2 (4.9)
Low-end 118 (20.6) 46 (19.9) 37 (20.9) 3 (7.3)
Moderate 148 (25.8) 52 (22.5) 45 (25.4) 12 (29.3)
Moderately-high 156 (27.2) 45 (19.5) 58 (32.8) 15 (36.6)
High 51 (8.9) 12 (5.1) 26 (14.7) 3 (7.3)
Self-esteem (SISE), mean (SD)a 5.9 ± 1.3 5.2 ± 1.6 < 0.001 6.2 ± 1.0 6.1 ± 1.2 0.633
QoL,(SF-12-MCS score), mean (SD)a 39.1 ± 12.5 35.3 ± 3.3 < 0.001 46.2 ± 12.6 47.0 ± 1.9 0.724
Lifestyle factors
Smoking status < 0.001 < 0.001
Never 106 (18.5) 182 (78.8) 42 (23.7) 34 (82.9)
Former 126 (22.0) 11 (4.8) 105 (59.3) 4 (9.8)
Current 341 (59.5) 38 (16.4) 30 (17.0) 3 (7.3)
Currently on diet 0.767 0.483
Yes 87 (15.2) 37 (16.0) 39 (22.0) 7 (17.1)
No 486 (84.8) 194 (84.0) 138 (78.0) 34 (82.9)
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score, the effects of gender on mediators and the effects
of mediators on CDS score.
There was no indication of confounding or moder-
ation by age. In the pooled model, age was not signifi-
cant when a direct effect of age on CDS score was added
to the model. There were also no significant differences
between corresponding effect estimates after SEM’s were
conducted separately for the two age groups < 59 years
and ≥ 59 years. These results are presented in Additional
file 1: Figure S1a and b.
The SEM conducted to assess whether resilience
could also be a mediator and/or moderator between
PTSD and depression (CDS score) revealed a signifi-
cant direct association between PTSD and depression
and a small positive moderating effect of resilience on
this association was observed. There were negative yet
significant associations between PTSD and resilience
and between resilience and depression (see Add-
itional file 2: Figure S2). Thus, in this SEM, resilience
appeared both as a mediator of the total effect of
Table 1 Bivariate comparison of study characteristics in men and women with CVD, by presence and absence of depressive
symptoms, N = 1022 (Continued)
Variable Sample with depressive Symptoms (CDS ≥90)
(N = 804)
Sample without depressive symptoms (CDS < 90)
(N = 218)
Male
(N = 573) N (%)
Female
(N = 231) N (%)
P value Male
(N = 177) N (%)
Female
(N = 41) N (%)
P value
Fat consumption < 0.001 0.075
Low 247 (43.1) 127 (55.0) 85 (48.0) 21 (51.2)
Medium 176 (30.7) 77 (33.3) 53 (30.0) 17 (41.5)
High 150 (26.2) 27 (11.7) 39 (22.0) 3 (7.3)
Vegetable & fruit consumption 0.920 0.789
Low 59 (10.3) 25 (10.8) 15 (8.5) 3 (7.3)
Medium 200 (34.9) 83 (35.9) 55 (31.1) 15 (36.6)
High 314 (54.8) 123 (53.3) 107 (60.4) 23 (56.1)
Alcohol use 0.004 0.100
Yes 35 (6.1) 3 (1.3) 11 (6.2) 0 (0.0)
No 536 (93.9) 228 (98.7) 165 (93.8) 41 (100.0)
Physical activity < 0.001 0.008
None 178 (31.1) 117 (50.7) 31 (17.5) 11 (26.8)
Not daily 116 (20.2) 37 (16.0) 24 (13.6) 12 (29.3)
Daily 279 (48.7) 77 (33.3) 122 (68.9) 18 (43.9)
BMI 0.083 0.230
Underweight 3 (0.5) 0 (0.0) 1 (0.6) 0 (0.0)
Normal weight 118 (20.6) 39 (16.9) 38 (21.5) 4 (9.8)
Overweight 236 (41.2) 84 (36.4) 87 (49.1) 20 (48.8)
Obese 216 (37.7) 108 (46.7) 51 (28.8) 17 (41.4)
Gender differences were assessed using Chi-squared and t-tests, respectively, both in patients with and without depressive symptoms
P values in bold are significant at p < 0.05
CDS Cardiac depression scale, HS High school, MI Myocardial infarction, CHD Coronary heart disease, CATH Catheterization, CABG Coronary artery bypass graft,
PHQ-15 Patient health questionnair-15, QoL Quality of life, SF-12 Short-form 12 health survey, PCS Physical component summary, SD Standard deviation, PTSD
Post-traumatic stress disorder, PTSD-PCL-S Post-traumatic stress disorder checklist, RS-14 Resilience scale-14, SISE Single-item self-esteem scale, ESSI ENRICHD social
support instrument, MCS Mental component summary, BMI Body mass index
aIndependent t test
Table 2 Frequency of levels of severity of depressive symptoms, by gender







< 90: no depression 218 (21.3) 177 (23.6) 41 (15.1) 0.003
90–100: mild to moderate depression 257 (25.2) 193 (25.7) 64 (23.5)
> 100: severe depression 547 (53.5) 380 (50.7) 167 (61.4)
CDS Cardiac depression scale
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PTSD on depression and a moderator of the respect-
ive direct effect.
Figure 3 illustrates the interaction between PTSD and
resilience, in which the difference in predicted depres-
sion (CDS score) between those with low and high resili-
ence decreases slightly with increasing PTSD symptoms.
This suggests that resilience shows a clearer protective
role at lower levels of PTSD, becoming less protective at
higher levels of PTSD.
No mediation by smoking of the association be-
tween PTSD and depression (CDS score) was found
(data not shown).
Discussion
In our sample of cardiac patients, women with CVD
have a higher prevalence of severe depressive symptoms
(61.4%) compared to men (50.7%). The association of
gender with depression was entirely explained by a num-
ber of mediators. The strongest positive mediator was
PTSD, which was more prevalent in women and posi-
tively associated with depression. While resilience itself
was a negative mediator of the gender-depression associ-
ation, it mediated and moderated the PTSD-depression
(CDS score) association. Besides mediation by psycho-
social parameters, lifestyle factors such as physical activ-
ity and smoking also explained part of the gender-
depression association.
Our findings that women with CVD were more likely
to experience depressive symptoms and at higher levels
than men with CVD were consistent with other studies
[50–52]. This finding is also consistent with the respect-
ive sex difference observed in the general population [9].
Previously, there has been evidence on gender being
linked to PTSD and comorbid depression as well as
PTSD and associated outcomes in cardiac patients.
However, to our knowledge, this is the first study to as-
sess direct and indirect effects of gender on depression
among a cardiac population, with a particular focus on
PTSD as a mediator. Previous studies have found that
women are at higher risk of comorbid PTSD and depres-
sion symptoms compared to men [53, 54], similar to our
findings which showed a direct significant association of
female gender with PTSD and a significant indirect ef-
fect of gender on depression mediated by PTSD. Reasons
for these gender differences could be attributed to the
different types of traumatic or stressful situations which
men and women are exposed to, different responses to
trauma, and different symptom-related responses, all of
which may affect the course and severity of symptoms
[55]. In addition, higher rates of PTSD and depression
among women could be due to women’s lower social
position which can lead to greater exposure to trauma
and stressors compared to men [56]. This could particu-
larly be true among our sample and in the cultural con-
text of Palestine, where women have much lower social
positions compared to men. In the present study,
women had more severe diagnoses, comorbidities and
complicated treatment procedures along with other
Fig. 1 Distribution of scores for symptoms of depression (CDS score) and PTSD score, by gender. Note. CDS=Cardiac Depression Scale (Possible
score range: 26–182; Actual score range: 47–155); PTSD = Post-traumatic Stress Disorder (Possible score range: 0–85; Actual score range: 0–71)
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negative daily stressors, suggesting that women were
more vulnerable to traumatic stress which arises from
both PTSD and depression and their comorbidity. Dao
et al., found increased mortality among comorbid PTSD
and depression patients after CABG to be linked to fe-
male gender [49]. These results have implications for
early assessment of these mental health disorders, as
their comorbidity is becoming more frequently observed
and prevalent in cardiac patients.
Our findings also reveal that low resilience is associ-
ated with being female and higher depressive symptoms
among our cardiac sample. This finding supports the re-
sults of a study by Carvalho et al. [57], which found that
among a CVD sample, lower scores of resilience were
associated with depressive symptoms and with female
gender, compared to men. This finding could indicate
that men tend to have more motivation to focus on
problem solving coping strategies, whereas women tend
to use emotion-focused coping strategies [11, 58]. Add-
itionally, another study which assessed for depression
using the CDS found a strong association between low
resilience and depression (CDS > 95) among CVD pa-
tients [59]. In our further analysis assessing mediation of
resilience between PTSD and depression (CDS score),
we found a significant effect for the interaction by resili-
ence of the association between PTSD and depression
(CDS score). We also found the difference in CDS score
between those with low and high resilience decreased
with increasing PTSD symptoms, potentially meaning
that higher levels of PTSD partly override the protective
effects of resilience. These findings suggest the need for
intervention targets such as group cardiac rehabilitation
and interventions to improve coping with adversities,
which could ultimately reduce the risk of depression and
strengthen resilience among cardiac patients. Further-
more, promoting physical activity among CVD patients
Fig. 2 SEM of the direct and indirect effects of gender on depression (CDS score), (N = 1022). Note. The pathways represented by arrows
correspond to direct and indirect effects of gender on depression (CDS score). Solid arrows (in bold) represent statistically significant associations
between variables and dashed arrows represent non-significant associations. Each arrow is labeled with the respective effect estimate and its
95%-confidence interval. The effect magnitudes on the arrows are not comparable to each other because the mediators have different scale
ranges.Gender was coded as 0 = male, 1 = female; IV = independent variable, DV = dependent variable, CDS=Cardiac Depression Scale, PTSD-PCL-
S=Post-traumatic Stress Disorder Checklist, RS-14 = Resilience Scale-14, SISE = Single-Item Self-Esteem Scale, SF-12-PCS = Short-form 12 Health
Survey-Physical Component Summary, PHQ-15 = the Patient Health Questionnaire-15; *p < 0.05, **p < 0.01, ***p < 0.001
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is recommended as resilience also has been linked to
exercise [60] and has been known to reduce the risk of
depression among resilient patients with CVD [59].
Higher somatic symptoms were also associated with
being female and higher depression levels in this study,
consistent with previous reports which found females
with major depression showed higher rates of somatic
symptoms compared to men [61, 62]. A study conducted
in Spain, which also used the PHQ-15 to assess for som-
atic symptoms, found women reported higher total
scores than men and were more concerned in 8 out of
15 items of the PHQ-15 [63]. Nonetheless, these findings
should be interpreted with caution since somatic symp-
tom scales vary in different studies.
Our results also reveal that physical inactivity is associ-
ated with being female and higher depressive symptoms
among our cardiac sample. It has been previously re-
ported that female cardiac patients frequently engage in
less exercise compared with their male counterparts,
despite the increasing evidence to support the beneficial
role of exercise among cardiac patients [64]. Physical in-
activity has been associated with depression and has
been shown to mediate the relationship between depres-
sion and cardiovascular events and mortality [65, 66]. A
recent systematic review found that depression could
lead to a sedentary lifestyle and lower levels of physical
activity [67]. These data along with our findings suggest
that there is need for exercise programs for CVD pa-
tients, especially women and those with depression.
Furthermore, our findings shed light on gender differ-
ences for socioeconomic factors among men and women
with both CVD and depressive symptoms. In the present
study, and similar to other studies, women were more
likely to be not married, unemployed, and less educated
[68, 69], compared to men with CVD and comorbid de-
pressive symptoms. These findings are supported by pre-
vious studies on CHD patients that female gender is
linked to lower education, which increases the risk of
onset of CHD [70], whereas employment and higher
education play a protective role against depressive symp-
toms [71]. Those with high socioeconomic status have
more self-esteem, more resources and social support, all
of which reduce the stress that comes with depression
compared to those with low socioeconomic status,
whom have less access to social and personal resources,
which increases stress levels. However, occupation and
marital status were not significant in the final SEM and
thus were not mediating effects of gender on depression
(CDS score).
Furthermore, in our sample, women had more
coexisting illnesses (i.e. diabetes and hypertension)
compared with men with cardiac disease, a finding
consistent with other studies [68, 69, 72]. There were
no major differences in rates of angina as an initial
cardiac diagnosis between men and women, which is
inconsistent with results in other studies, which found
higher angina rates among women compared with
men [73, 74].
Fig. 3 Association of PTSD and CDS stratified by level of resilience. Note. CDS = Cardiac Depression Scale; PTSD = Post-traumatic stress disorder
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Strengths
This study had several strengths. First, the high par-
ticipation rate decreased the likelihood of selection
and participation bias. Second, our sample of women
was relatively large, compared to other studies, which
provided sufficient statistical power for testing gender
differences. Third, the CDS used in the study is the
only psychometric scale suitable for the comparative
depression assessment in heart disease patients, sub-
jected to different interventions and has excellent
properties for the diagnosis of severe depression, a
score > 100 having a sensitivity of 88% and a specifi-
city of 84%. Finally, the findings of our study are
likely generalizable as our sample was recruited from
four main hospitals of Nablus, Palestine, which pro-
vide cardiac care to a large percentage of individuals
in the area.
Limitations
The limitations of our study are due to several sources.
First, depression was not formally diagnosed by a psy-
chological interview and was rather assessed using the
CDS, thus we cannot conclude that our sample had clin-
ical depression. However, the identification of certain
mediating factors of gender on depression among car-
diac patients can serve as a basis for developing the best
intervention targeting depression among women and
men with cardiac disease. Second, some patients were
recruited at the time of admission and for the most part
before receiving their intervention or diagnosis, and thus
were under stress and anxiety. As some of the anxiety
observed may have been transient, the level of depres-
sion and anxiety could have been overestimated. Finally,
due to the cross-sectional design of the study the direc-
tion of associations cannot be derived with certainty and
causality cannot be inferred.
Conclusion
This study demonstrated that, similar to the general
population, the prevalence of severe depression is
greater in female patients with cardiac disease com-
pared to male patients. Overall, our findings provide
new information documenting mediating factors, in
particular PTSD, of the association between gender
and depression among cardiac patients. These findings
emphasize the need to devote more attention to iden-
tify and address potential mediating factors that could
account for gender differences in depression. Provid-
ing supportive programs for female patients with
CVD to improve their psychosocial well-being in car-
diac rehabilitation seems of particular importance in
conflict-prone areas, like Palestine.
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